Column Capital Advisors’s Exact Sciences EXAS Stock Holding History

Column Capital Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$6.82K	Sell	100 -100	-50%	-$8.48K	﹤0.01%	568
2023 Q2	$18.8K	Hold	200	–	–	﹤0.01%	447
2023 Q1	$13.6K	Sell	200 -150	-43%	-$9.64K	﹤0.01%	496
2022 Q4	$17.3K	Hold	350	–	–	﹤0.01%	440
2022 Q3	$11K	Buy	350 +60	+21%	+$2.47K	﹤0.01%	454
2022 Q2	$11K	Buy	290 +225	+346%	+$12K	﹤0.01%	463
2022 Q1	$5K	Buy	+65	New	+$4.75K	﹤0.01%	575

Other funds holding EXAS

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Column Capital Advisors's EXAS Position: Q3 2023 in Review

Column Capital Advisors reduced its Exact Sciences (EXAS) stake by 50% in Q3 2023, selling an estimated $8.48K and leaving 100 shares worth $6.82K. The position accounts for ﹤0.01% of the portfolio, ranked #568.

Column Capital Advisors first reported a position in EXAS in Q1 2022 and has held it in 7 quarters since. The position peaked at $18.8K in Q2 2023. 623 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

Column Capital Advisors held 100 shares of Exact Sciences worth $6.82K as of Q3 2023.
Column Capital Advisors sold 100 Exact Sciences shares in Q3 2023, an estimated $8.48K.
Exact Sciences made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #568 holding.
Column Capital Advisors first reported a position in Exact Sciences in Q1 2022 and has held it in 7 quarters since.
Column Capital Advisors's Exact Sciences position peaked at $18.8K in Q2 2023.
623 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.